Chilton dismisses Nymex contracts

Benfield chief executive Grahame Chilton has dismissed the forthcoming Nymex-CME 'Re-Ex Index' tradable contracts as merely a revamp of a similar scheme his company had in the early nineties. "I think

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here:

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: